南京科佰生物科技有限公司

主營產(chǎn)品: atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫購買

11

聯(lián)系電話

18066071954

您現(xiàn)在的位置: 南京科佰生物科技有限公司>>基因檢測標(biāo)準(zhǔn)品>>Mutation>> CBP10622AI-Edigene® ESR1 p.Y537S Reference Standard P

公司信息

聯(lián)人:
蔣經(jīng)理
話:
4008750250
機(jī):
18066071954
真:
址:
南京市棲霞區(qū)緯地路9號(hào)
編:
210000
個(gè)化:
www.co-bioer.com
網(wǎng)址:
www.cobioer.com/
鋪:
http://true-witness.com/st281842/
給他留言
CBP10622AI-Edigene® ESR1 p.Y537S Reference Standard P
AI-Edigene® ESR1 p.Y537S Reference Standard P
參考價(jià) 面議
具體成交價(jià)以合同協(xié)議為準(zhǔn)
  • 型號(hào) CBP10622
  • 品牌 cobioer/科佰生物
  • 廠商性質(zhì) 代理商
  • 所在地 南京市

更新時(shí)間:2023-09-07 10:46:53瀏覽次數(shù):974

聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!

【簡單介紹】
供貨周期 現(xiàn)貨 規(guī)格 1ug
貨號(hào) CBP10622 應(yīng)用領(lǐng)域 生物產(chǎn)業(yè)
AI-Edigene® ESR1 p.Y537S Reference Standard Plus
【詳細(xì)說明】
CBP10622
FormatGenomic DNA
DescriptionESR1, estrogen receptor alpha, modulates response to estrogen and is used as a marker to predict response to endocrine therapy in breast cancer patients. ESR1 fusions are recurrent in breast cancer, and mutations in ESR1 have been associated with decreased response to endocrine therapy in breast cancer.
  
Technical Data 
DNA Changec.1610A>C
AA Changep.Y537S
Mutation typeSubstitution - Missense
ZygosityHomozygous
Allelic Frequency100%
TranscriptN/A
Cosmic IDCOSM1074639
Chr position(GRCh37)chr6:152419923
BufferTris-EDTA
  
Product Information 
Intended UseResearch Use Only
Unit Size1ug
ConcentrationDownload for COA
PuroficationDownload for COA
DNA electrophoresisDownload for COA
Sanger sequencing

CBP10622 ESR1 Y537S-C38.png

Storage4℃
Expiry36 months from the date of manufacture




產(chǎn)品對(duì)比 產(chǎn)品對(duì)比 二維碼 在線交流

掃一掃訪問手機(jī)商鋪

對(duì)比框

在線留言